CDC Expects Similar Hospitalizations for COVID-19, RSV, and Flu This Year
The U.S. Centers for Disease Control and Prevention (CDC) announced that it foresees a comparable number of hospitalizations for COVID-19, respiratory syncytial virus (RSV) infections, and the flu this year compared to the previous year. This number is expected to be higher than the levels before the pandemic hit.
Additionally, the CDC anticipates a rise in both flu and RSV infections during the upcoming fall and winter seasons. But, there’s some good news on the horizon. The CDC confirmed that vaccines for these three major respiratory viruses – COVID-19, flu, and RSV – will be accessible this autumn.
Why Vaccination Matters
Increasing the vaccination rates across the population is crucial. It helps lower the number of people needing hospitalization and eases the strain on our healthcare system. Think of it as a collective shield to protect our health and our hospitals.
Just recently, the CDC gave the green light for the expanded use of updated COVID-19 vaccines by Pfizer, BioNTech SE, and Moderna. These vaccines are now available for those aged 6 months and older, as the nation gears up for a vaccination campaign set to begin very soon.
As we move forward, there’s an interesting twist: a surge in RSV cases aligning with increased COVID transmission and an earlier-than-expected flu season. This has led to concerns about the possibility of a ‘tripledemic,’ where three respiratory illnesses may simultaneously challenge the United States.
So, as we head into the cooler months, it’s more important than ever to consider getting vaccinated against these viruses to keep yourself and those around you safe.